How to administer Wegovy (semaglutide) injection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Administer Wegovy (Semaglutide) Injection

Wegovy is not a pill—it is a subcutaneous injection administered once weekly using a pre-filled pen device. 1

Preparation Before Each Injection

  • Wash your hands thoroughly with soap and water before handling the pen 1
  • Check the pen label to confirm it says "Wegovy" or "OZEMPIC" (the brand name for lower-dose semaglutide), as this is critical if you use multiple medications 1
  • Inspect the medication through the pen window—the solution must be clear and colorless; do not use if it appears cloudy or contains particles 1
  • Remove the pen cap and attach a new needle by pushing it straight onto the pen and turning until tight 1

Critical Needle Safety Rules

  • Always use a new needle for each injection—this reduces contamination risk, prevents infection, avoids medication leakage, and prevents blocked needles that deliver incorrect doses 1
  • Never reuse or share needles with other people, as this can transmit serious infections 1
  • Never use bent or damaged needles 1

First-Time Pen Setup (Flow Check)

  • For each new pen only, you must check medication flow before the first injection 1
  • Turn the dose selector until the flow check symbol (▶) appears 1
  • Hold the pen with needle pointing upward, press and hold the dose button until the counter shows "0" 1
  • A drop of medication must appear at the needle tip—if no drop appears after 6 attempts, change the needle and try once more 1
  • If still no drop appears, contact Novo Nordisk at 1-888-693-6742, as the pen may be defective 1

Selecting Your Dose

  • Turn the dose selector until it stops at your prescribed dose (typically 2.4 mg for Wegovy at maintenance) 1
  • The dose counter will click with each turn—do not count clicks to set your dose; always verify using the dose counter display 1
  • The selected dose must line up exactly with the dose pointer to ensure accuracy 1

Injection Technique

  • Choose an injection site: abdomen, thigh, or upper arm—rotate sites with each injection 1
  • Clean the site with an alcohol swab and allow it to dry completely 1
  • Insert the needle straight into your skin at a 90-degree angle as demonstrated by your healthcare provider 1
  • Press and hold the dose button until the dose counter shows "0"—you may hear or feel a click 1
  • Keep the needle in your skin and count slowly to 6 after the counter reaches "0" to ensure complete dose delivery 1
  • If you remove the needle too early, you may see medication streaming from the needle tip, indicating incomplete dose delivery 1

After Injection

  • Remove the needle from your skin—light bleeding is normal; press gently with gauze but do not rub 1
  • Immediately place the used needle in a sharps disposal container without recapping to prevent needle stick injuries 1
  • Replace the pen cap to protect the medication from light 1
  • Store the pen at room temperature or in the refrigerator according to package instructions 1

Dosing Schedule and Titration

  • Wegovy requires gradual dose escalation over 16 weeks to minimize gastrointestinal side effects 2
  • Standard titration: 0.25 mg weekly for 4 weeks → 0.5 mg weekly for 4 weeks → 1.0 mg weekly for 4 weeks → 1.7 mg weekly for 4 weeks → 2.4 mg weekly (maintenance dose) 2
  • Inject once weekly on the same day each week—you can change the day if needed, as long as at least 2 days (48 hours) pass between doses 2

Missed Dose Management

  • If you miss 1-2 consecutive doses: Resume at your current dose if you tolerated it well previously 2
  • If you miss 3 or more consecutive doses: Contact your healthcare provider, as you may need to restart the titration schedule to avoid severe gastrointestinal side effects 2

Critical Safety Warnings

  • Never use Wegovy with other GLP-1 receptor agonists (like Ozempic, Trulicity, Victoza) or DPP-4 inhibitors 2
  • If taking insulin or sulfonylureas, monitor closely for hypoglycemia and expect dose adjustments of these medications 2
  • Wegovy delays gastric emptying, which may affect absorption of oral medications requiring rapid onset 2

Common Pitfalls to Avoid

  • Do not skip the flow check with each new pen—this is the only way to confirm the pen is working properly 1
  • Do not touch or cover the dose counter while injecting, as this can stop medication delivery 1
  • Do not try to withdraw medication with a syringe from the pen device 1
  • Do not dispose of needles in household trash—use an FDA-cleared sharps container 1

Practical Considerations

  • Always carry a spare pen and extra needles in case of loss or damage 1
  • Keep pens and needles out of reach of children 1
  • Gastrointestinal side effects (nausea, vomiting, diarrhea) are common but typically decrease over time with gradual dose escalation 3, 4

References

Guideline

Ozempic Dosing and Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical review of subcutaneous semaglutide for obesity.

Journal of clinical pharmacy and therapeutics, 2022

Related Questions

What are the dose forms and administration guidelines for Wegovy (semaglutide)?
What is the recommended dose of Wegovy (semaglutide) for a patient with no history of pancreatitis, thyroid cancer, or kidney disease?
What is the recommended dosage and usage of Wegovy (semaglutide) for weight management?
What is the recommended dosing schedule to initiate Wegovy (semaglutide)?
What is the recommended dosing schedule for Wegovy (semaglutide) in a patient with impaired renal function or a history of pancreatitis or thyroid cancer?
What is the next step in managing an adult patient with no significant medical history and impaired depressive symptom control despite adequate treatment with trazodone (a serotonin antagonist and reuptake inhibitor)
What is the next treatment step for a patient with persistent hyponatremia despite treatment with 3% (three percent) saline?
How often should spirometry or lung function testing be performed for patients with asthma, particularly those with severe asthma or a history of recent exacerbation?
What is the risk of permanent hand tremors in patients taking Olanzapine (olanzapine), particularly in the elderly or those with a history of neurological disorders?
Will Apriso (mesalamine) lower fecal calprotectin levels in a patient with ulcerative colitis or do these levels fluctuate regardless of treatment?
What are the potential risks and management strategies for an older adult patient with depression, anxiety, insomnia, and possible Parkinson's disease, who is taking fluoxetine, bupropion, ropinirole, hydroxyzine, mirtazapine, and trazodone?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.